August 1, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a

Continue Reading

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon,

Continue Reading

Police to restore law and order in Riverlea

Police Minister, General Bheki Cele, has assured the community of Riverlea that police are mobilising all their resources and specialised units to restore law and order in the area.On Monday, Cele led a high level delegation of senior police officers …

Continue Reading

Rhino killings decrease by 11%

In the first six months of this year, 231 rhinos were killed in South Africa, representing an 11% decrease when compared to the same period last year.This represents a decline of 28 animals killed for their horn.Addressing a media briefing on Tuesday,…

Continue Reading

Recent Posts